Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes Sir toohot, that day is coming
Top 6 volume days for BIEL:
5/2/2018 ...... 949,369.060 shares
11/27/2018 .... 798,168,870 shares
7/1/2019 ...... 753,798,330 shares
6/18/2019 ..... 683,903,590 shares
5/17/2017 ..... 604,012,140 shares
8/2/2019 ...... 536,867,290 shares
Those dates are 'Estimated' Pro
I am guessing that they give a wide window to allow for possible delays.
The term 'pilot study' is used meaning a larger study would be done if the researchers are satisfied with the parameters and results.
Thumb Arthritis is a great Trial for ActiPatch to shine:
* Easy to focus the Patch exactly on the target (thinking BIEL supplied 'eye' sized Patches)
* Small area near the skin surface
* 4 weeks of nightly therapy will be plenty of time for ActiPatch to relieve pain
Notice that this is a "Stanford Sponsored Study", it is not BIEL sponsoring a Study carried out by Stanford.
Stanford ActiPatch Arthritis Study Now on Clinicaltrials.gov
Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis
Sponsor:
Stanford University
Information provided by (Responsible Party):
Raymond Chou, Stanford University
Device: PEMF device
PEMF device wear overnight daily for four weeks
Other Name: ActiPatch
Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain and improves function in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA) and if this is secondary to physiological changes.
https://www.clinicaltrials.gov/ct2/show/NCT05315297
It has been 17 months since the CE Mark Approval
Having RecoveryRx approved for OTC gives distributors options. Some may want to keep it as a medical professional device which commands a higher price.
As far as the CE Mark in general, it is an advantage in negotiating and signing deals even in non-EU countries.
"Around the world, up to 70-80% of markets in some way rely on or reference the CE marking. It can also provide an advantage in some markets when procurement deals are being negotiated. “The impact is quite broad,” said the MTE director."
"Most of the ASEAN economies are thought to accept the CE marking as a route market – not as an exclusive route to market – but factored into the market entry process, in the example of Singapore. As a rough estimate, some 50% of all products that enter the ASEAN markets in some way use or rely on the CE marking."
https://medtech.pharmaintelligence.informa.com/MT143654/Device-Firms-In-Non-EU-Markets-Using-The-CE-Mark-Should-Expect-Some-MDR-Disruption-After-May
New CE Mark of 11/12/2020 Gave OTC Status to both ActiPatch and RecoveryRx
FREDERICK, MD, Nov. 12, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that it has received the CE (Conformité Européenne) Mark for its ActiPatch® and RecoveryRx® Pulsed Shortwave Therapy (PSWT) medical devices.
The ActiPatch is indicated for the treatment of general musculoskeletal/soft-tissue pain, while the RecoveryRx is indicated for the treatment of postoperative pain. These wearable devices can now be sold over the counter in 33 European Union (EU) countries, and many other non-EU countries like Australia that recognize the CE mark.
RecoveryRx does not need a prescription per the CE Mark in the following countries:
Austria
Belgium
Bulgaria
Croatia
Cyprus*
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Italy
Latvia
Lithuania
Luxembourg
Malta
The Netherlands
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Iceland
Lichtenstein
Norway
Switzerland
the Åland Islands
the Azores
the Canary Islands
French Guiana
Gibraltar
Guadeloupe
Madeira
Martinique
Mayotte
Réunion
Saint Martin
Prim Group PR is Out
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
April 06, 2022 06:00 ET | Source: BioElectronics Corporation
...
FREDERICK, MD, April 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain.
"PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx in an important market in Europe,” said Kelly Whelan, President of BioElectronics.
“Our goal is to continue expanding our network of qualified distributors with knowledgeable sales and support personnel, and in close proximity to our customers,” added Erin Sanders, Manager of International Sales for BioElectronics Corporation.
PRIM Group is expected to provide sales, marketing, and distribution services throughout Spain for RecoveryRx. The RecoveryRx medical device is designed to provide drug-free relief of post-surgical pain. RecoveryRx is a single use device designed to provide 720 hours of therapy. RecoveryRx is both US FDA cleared, and CE marked.
About PRIM Group: PRIM is a Spanish public company that has been listed on the Stock Exchange since 1985 and adds value to the healthcare system. PRIM designs, manufactures, commercializes, installs and keeps products and equipment providing advanced solutions. PRIM provides comprehensive continuous service via its headquarter offices, two plants, seven regional offices, four warehouses and six orthopedic clinics. It develops its main activity in Hospitals, Clinics, Healthcare Centers, Health Insurances, Orthopedics, Individuals, Chiropody Centers, Chemist's, and Medical Societies.
https://www.globenewswire.com/news-release/2022/04/06/2417357/0/en/BioElectronics-Corporation-Enters-Into-a-Distribution-Agreement-For-RecoveryRx-in-Spain-With-PRIM-Group.html
https://finance.yahoo.com/news/bioelectronics-corporation-enters-distribution-agreement-100000838.html
https://seekingalpha.com/news/3821026-bioelectronics-signs-distribution-agreement-for-recoveryrx-in-spain
Yep JGD, It was 'MM Miricale Tuesday'
A 20,000 Ask Size Filled over 6 Million shares of Buys.
At the end of the day the MMs could not deliver 30 million shares.
date................. short........total volume
20220405|BIEL|30737610||54820353
Last 2 minutes of trading:
Time.....Price....Last Size ..Bid Price Bid Size .. Ask Price Ask Size
15:59:32 .. 0.0011 .. 50000 0.001 ... 87750296 .... 0.0011 20000
15:59:11 .. 0.001 ... 1100000 0.001 ... 87750296 .... 0.0011 20000
15:58:28 .. 0.0011 .. 4045344 0.001 ... 87750296 .... 0.0011 20000
15:58:27 .. 0.0011 .. 500000 0.001 ... 87750296 .... 0.0011 20000
15:58:26 .. 0.0011 .. 500000 0.001 ... 87750296 .... 0.0011 20000
15:58:25 .. 0.0011 .. 500000 0.001 ... 87750296 .... 0.0011 20000
15:58:23 .. 0.0011 .. 500000 0.001 ... 87750296 .... 0.0011 10000
15:58:22 .. 0.0011 .. 10000 0.001 ... 87750296 .... 0.0011 10000
15:58:20 .. 0.0011 .. 10000 0.001 ... 87750296 .... 0.0011 20000
15:58:18 .. 0.0011 .. 3934656 0.001 ... 87750296 .... 0.0011 3954656
KW is giving a preview of tomorrow's Press Release
Notice the "Globe Newswire".
This is a Billion $$$$$$ company that will be promoting RecoveryRx.
Their Opening Order will make a large impact on Q2.
Kelly Whelan
2h ·
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
FREDERICK, MD. April 6, 2022 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain.
"PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx in an important market in Europe,” said Kelly Whelan, President of BioElectronics.
“Our goal is to continue expanding our network of qualified distributors with knowledgeable sales and support personnel, and in close proximity to our customers,” added Erin Sanders, Manager of International Sales for BioElectronics Corporation.
PRIM Group is expected to provide sales, marketing, and distribution services throughout Spain for RecoveryRx.
https://www.facebook.com/kelly.whelan.12
Wow JGD!!!, Prim is a Major Spanish Company
<<<<<<<<<<<< Biel's New RecoveryRX Distributor!! >>>>>>>>>>>>>>>
* $1.6 Billion in Sales
* In business for 150 years
* 600 Employees
* Exporting products to 75 countries
* 6 Divisions
** PRIM Hospitals
** PRIM Orthopedics
** PRIM Orthopedic Clinics, 13
** PRIM Physio
** PRIM Pharma
** PRIM Spa
Kelly Whelan
2h ·
BioElectronics Corporation Enters Into a Distribution Agreement For RecoveryRx in Spain With PRIM Group
FREDERICK, MD. April 6, 2022 -- (GLOBE NEWSWIRE) -- via NewMediaWire -- BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical technology products, today announced that the Company has entered into a distribution agreement with Madrid / Spain based PRIM Group (www.prim.es) for the distribution of its RecoveryRx device throughout Spain.
"PRIM Group in Spain serves as a perfect call point fit to provide a successful distribution of RecoveryRx in an important market in Europe,” said Kelly Whelan, President of BioElectronics.
“Our goal is to continue expanding our network of qualified distributors with knowledgeable sales and support personnel, and in close proximity to our customers,” added Erin Sanders, Manager of International Sales for BioElectronics Corporation.
PRIM Group is expected to provide sales, marketing, and distribution services throughout Spain for RecoveryRx.
https://www.facebook.com/kelly.whelan.12
rdw, a pretty glaring problem with that study
Expecting 68 year old patients, with limited mobility due to bad knees, to jump right into a 60 minute workout is not realistic. And that is why only one-third of the 'prehab group' showed up for the workouts.
Only being able to verify that 33% of 'prehab group' actually did the prehab workouts blows a big hole in the study. Coincidentally 34% of the 'prehab group' met the study mobility goals.
"For her research, Nguyen studied 178 women and 84 men with a mean age of 68.6 years who were candidates for surgery because of worsening osteoporosis"
"the “prehab” consisted of four 90-minute sessions which included 30 minutes watching an educational slideshow followed by 60 minutes of exercise."
"only one-third of the patients attended the supervised prehab sessions"
"Four days after surgery 27% of the control group, who did not do have rehabilitation, and 34% ? not significantly more ? of the group that had prehabilitation were able to perform these basic functions"
"Dr. Bert Mandelbaum, a professor of orthopedics at Cedars-Sinai Kerlan-Jobe Institute in Los Angeles, told Medscape: “As far as I can see there’s no way to determine what the people were doing or not doing in the control group.”"
"Clinicians should recommend exercise to their patients before surgery, he said. “It’s just common sense.”"
Yep pinhigh, Country List so Big it's hard keeping track of
The biggest event regarding International Sales has to be the CE Mark Approval on 11/12/2020. This one regulatory approval opened up 33 countries to both ActiPatch and RecoveryRx Sales.
Another big win for boosting International Sales was obtained in early 2021 when BIEL was approved for the Medical Device Single Audit Program (MDSAP). This program, initially comprised of the US FDA, Japan, Brazil, Australia, Canada, is working toward one Medical Device Clearance that will be honored in all countries. The MDSAP will save medical device companies millions of dollars and years of time in navigating individual country regulations.
As for recent Partners these come to mind, no doubt missing several:
ActiPatch/RecoveryRx - Kuwait, Oman, Qatar
ActiPatch- Saudi Arabia, Bahrain, South Africa
RecoveryRx - Mexico, UAE
KT Wave - UK, Japan, Australia, Latvia, Lithuania, Estonia
$200k+ in New International Orders were confirmed in Q1 2022
We know that 11 pallets headed to Multiple Health Pharma were shipped in Q1.
KW later confirmed that MHP is a supplier to the Bangledsh Military (217k personnel).
KT is a sports oriented brand so they are likely to see more sales in the Spring and Summer when customers are more active.
Sports are an important aspect of DonJoy's business also and they are over due for some serious Advantage EME promotion.
SAI is due to launch their 'Powered By ActiPatch' line of Wraps in Q2. They will need a large opening order as they have 7 Wraps, most having 2 sizes, along with a Replacement Device and a 7 Day Trial Device.
Q1, 2, 3 have a Financial Filing due date 45 days after the Quarter end.
EOY Financials, of which Q4 is a component, are due 90 days after the EOY.
Good catch Hawk, I was hoping that the SAI Launch might light a fire under DJO as SAI is direct 'PSWT device with wrap' competition
A company would want to adjust any pricing before starting a promotional campaign.
DJO, owned by Colfax Corp, is in the process of being separated from Colfax to operate independently as 'Enovis'.
https://www.globenewswire.com/news-release/2022/03/11/2401820/0/en/Colfax-Announces-Board-of-Directors-for-Enovis-the-Post-Spinoff-Medical-Technology-Company.html
This separation, ongoing for the last year, could be the reason for the delay in any serious 'Advantage EME' promotion.
Reminder of SAI 'Powered By ActiPatch' Launching this Spring:
2210 / ActiPatch 7 Day Trial
2211 / ActiPatch Kinesiology Tape
2212 / ActiPatch Replacement Device
2213 / ActiPatch Lower Back Wrap (Medium, Large, XL)
2214 / ActiPatch Shoulder Wrap (Regular and Large)
2215 / ActiPatch Compression Knee Sleeve (Regular and Large)
2216 / ActiPatch Compression Ankle Support (Regular and Large)
2217 / ActiPatch Plantar-Fasciitis Support (Regular and Large)
2218 / ActiPatch Wrist Support (Regular and Large)
2219 / ActiPatch Elbow Support (Regular and Large)
https://imgur.com/a/N3GA6Wj
LMAO, Guess it's hard to spell a 'Fantasy Company' correctly
<<<<<<< Sales Trak issues SELL recommendation >>>>>>>> 3/28/2022
<<<<<<< Retail Sales Track showing steep >>>>>>>>>>>>> 2/12/2022
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167868454
<<<<<<< Sales-Trac showing steep retail sales >>>>>>>> 1/13/2022
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=167486899
BIEL provides Quarterly Sales figures 45 days after the end of the Quarter and Yearly Sales figures 90 days after the EOY per the OTC Markets requirements.
Any claims of "sales tracking" or "sell recommendations" are Total BS.
Yep Jakman, Someone Jumped In with Both Feet
9:52, 17 million shares purchased at 11 . That is a $18,700 investment.
An MM I have not seen before 'INTL' has 1 million shares offered at .008 .
Go BIEL !!!
More Misinformation
<<<<<<<<<< You mean .0073 mV actually does all that? >>>>>>>>>>>>
"mV" is a Voltage measurement. ActiPatch power output is rated in Wattage, 73 microwatts or 73 uW.
The power source for ActiPatch is a 3 volt battery.
".0073 mV" is in no BIEL documents that I have seen.
From the FDA 510k Summary document for Clearance k192234:
Carrier frequency - 27.12MHz
Peak spatial power density - 73 microwatts/ cm²
Pulse rate - - 1000 pulses per second
Pulsed on duration - 100 micro seconds
Power source Battery - CR2032 or CR1632 or CR1620
Antenna size - 12cm or 6 cm diameter
Treatment area - 110cm2 or 30cm2
Weight - 9.5 grams
Operation time - (lifetime of battery) 720 hours or 360 hours or 168 hours
User Control - On/Off switch or On-only (continuous use) switch
Recommended Treatment Time - Minimum of 12 hours per day, up to 24 hours
<<<<<<<<<<<<<< Why didn't the FDA choose BIEL as the winner in the OP Challenge? >>>>>>>>>>>>>>
This question has been answered 100 times, but hey lets make it 101.
There were over 250 entrants in the 'FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder'.
Companies like Pfizer who spend hundreds of millions of $$$$$$ on R&D entered and had the same result as BIEL.
Of the 8 selected companies two were involved in 'Pain Therapy'.
Thermo Tek Inc. is working on a device to relieve Pain with Pneumatic
Compression.
CognifiSense is working on a device to relieve Pain with Virtual Reality Neuropsychological Therapy.
Neither one of these devices will weigh 9.5 grams, will cost $29, will sell OTC, and will allow the user to go about their daily routine so they are not competition to BIEL.
Doubling Down on the BS
<<<<<<<<<<< KT has over 4,000 items in its cataloge >>>>>>>>>>>>>
Anyone can go to the KT Website and see that KT sells 51 Products.
https://www.kttape.com/collections/kt-tape-products?page=1
The newest addition to their Product Line, KT Recovery+ Wave, gave KT the ability to advertise as offering FDA Cleared Products. This is worth millions $$$$ in Brand Clout to KT.
LOL, only off by 3,949.
LOL, Just an Opinion that BIEL went to 187 Venture Capital asking for money until proof is posted, Opinions abound, Facts not so much
What can be proven are BIEL's current Business Partners:
* $3 Billion Stada, sales organizations in 120 countries, 12,000 employees
* $1.2 Billion DJO Global, recently acquired for $3.15 billion by the Colfax Corp
* Multi Million $$$ KT Health, owned by Private equity firm Palladin Consumer Retail Partners
* Multi Million $$$ Surgical Appliance Industries, 125 year old medical products company, Canadian branch Airway Surgical Appliances
* Multi Million $$$ Adcock Ingram, 125 year old pharmaceutical/medical products manufacturer and distributor
Good catch Pro, Military Contracts are exactly what BIEL needs
The Bangladesh Military has 227,000 personnel.
Larger than Spain and Germany.
This shipment was confirmed by BIEL's COB 2/28/2022 Letter
Anyone who has evidence that this Letter contains false information should talk to the SEC.
SALES UPDATE:
BioElectronics Corporation is pleased to announce that it has signed two additional international distribution partners and received a new order from its longtime distribution partner in Bangladesh, Multiple Health Pharma, Ltd., who has resumed operations following shutdowns due to Covid. These two new international orders and the renewal order total in excess of $200,000.00.
https://www.bielcorp.com/bioelectronics-corporation-chairman-richard-staelin-ph-d-updates-company-achievements/
Thanks TP, That is a Substantial Shipment
Looks like 11 Pallets with 9 master pack cartons per pallet headed out the door.
https://www.facebook.com/BioElectronics/
You do realize that KT Wave is now in Target also right?
Do you think that there might be some strategy regarding Target vs CVS for Wave placement? Also KT is a Sports oriented brand so communities with demographics that reflect an active lifestyle will be targeted.
The Target and CVS shelf space is not free. KT pays Slotting Fees for each store so the Marketing dept at KT has to decide which stores to stock for the best results.
Placing the Wave in every one of the 9,800 CVS stores and 1,900 Target Stores will not happen until KT Wave gets the name recognition of an Advil or Tylenol.
Target Wave inventory from Target Website for "Chicago 60202":
60202
More near you
Evanston
1 mile
In stock - only 4 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago Wilson Yard
5 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Niles
5 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago Mid North
6 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago Near North Elston
7 miles
In stock - only 2 left
Not eligible for Order Pickup
Open until 10pm
Glenview
8 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago Brickyard
9 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago Gold Coast
9 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago West Loop
11 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago South Loop
12 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chicago McKinley Park
13 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Broadview
15 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Woodfield
19 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Hodgkins
19 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Vernon Hills
20 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Lombard
21 miles
In stock - only 2 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Warrenville
30 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Pleasant Prairie
39 miles
In stock - only 3 left
Ready within 2 hours for pickup inside the store
Open until 10pm
Chronic Pain Is a frequent cause of Depression/Anxiety, ActiPatch can relieve Chronic Pain
<<<<<<<<<<<< How has it (ActiPatch) helped mental issues ? >>>>>>>>>>>>>
"Chronic pain is a widespread problem in the United States. According to statistics from the Centers for Disease Control and Prevention, an estimated 50 million Americans suffer from some form of chronic pain; nearly 20 million of those people have high-impact chronic pain , which is persistent and affects a person’s ability to carry out day-to-day activities, resulting in a lower quality of life. Chronic pain is also frequently associated with a higher prevalence of mood disorders such as depression and anxiety."
https://www.washingtonpost.com/lifestyle/wellness/new-approaches-to-treating-chronic-pain-include-more-support-and-focusing-on-overall-wellness/2019/10/11/9df776ee-ea07-11e9-9c6d-436a0df4f31d_story.html
"Chronic pain is usually defined as any persistent or intermittent pain that lasts more than 3 months, which can be categorized along a variety of dimensions, including one of the most important divisions, neuropathic versus nociceptive pain [1, 2]. Neuropathic pain is induced by a lesion or disease involving the nervous system [3], and nociceptive pain occurs as a consequence of actual or threatened damage to nonneural tissue [4]. Chronic pain is a major public health problem, with epidemiological studies reporting that in the USA and Europe, approximately one fifth of the general population are affected [5]. Additionally, as one of the most common and disabling mental disorders, depression has been reported to be the third leading contributor to the global disease burden [6, 7]. Clinical studies have revealed that chronic pain, as a stress state, often induced depression [8–10] and that up to 85% of patients with chronic pain are affected by severe depression [11, 12]."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494581/
Smart Insole s still listed on the CICD website
https://cicdtech.en.made-in-china.com/product/KCGxLzlhnZVk/China-OEM-Foot-Pain-Relief-Device-Smart-Insole-Pulse-Physical-Therapy-Medical-Supply.html
BIEL's Mfg, CICD, provided a shelf ready product for KT USA
<<<<<<< Biel is not doing the packaging, KT Tape is >>>>>>>>
Shipments from CICD direct to KT Tape:
12/21/2020, 9,554 lbs, 3,770 cartons
4/25/2021, 11,384 lbs, 4,332 cartons
6/27/2021, 7,788 lbs, 2,848 cartons
These are not bulk shipments of devices that KT is packaging they are cases of retail ready, packaged products.
Same with the KT shipments to ROW. KT is not shipping bulk devices to Utah, packaging them, and shipping them to the UK, Australia, Spain, ect..
Thet go shelf ready from China to ROW.
CICD has the same 'Clam Shell' box that the KT Wave uses displayed on their website with ActiPatch labeling.
https://cicdtech.en.made-in-china.com/
Everything you wanted to know about Viant
https://viantmedical.com/
E: info@viantmedical.com
Address
2 Hampshire Street, Foxborough, MA, 02035, United States
Qualifications: ISO 9001, ISO 13485, FDA Registered, CGMP Certified, Supplier to Medical Manufacturers
Markets Supplied: North America, Europe, Worldwide
Viant is a global strategic manufacturing partner that helps medical device OEMs bring complex medical devices and components to market. Our deep materials expertise, combined with our experience in design, manufacturing, assembly, and packaging, allow us to bring our customers’ medical technology solutions to life. With nearly 6,000 associates across 24 locations worldwide, we are a unique combination of big-company scale and small-company attention.
- 24 locations worldwide
- 6000 associates worldwide
- 2.1M sq. ft. of manufacturing & assembly space
- 325k sq. ft. of clean room space
- 450 plastics processing machines
- 425 precision machining centers
- 30 million feet metal tubing produced annually
Markets
Surgical Technologies
Orthopedics
Cardiac & Vascular
Drug Delivery
Diagnostics
End-to-End Service Provider
Design & Development
DFM/DFA/DFX
Tool Design
Product Design & Development
Co-Development Products
Test Design and Development
Project Management
Materials
Implantable materials – metals and plastics
Instrument materials including – Ti, SS, Nitinol, other alloys & more
Engineered plastics
Elastomers / Silicones
Components
Injection Molding
Micro Injection Molding
Medical Blow Molding
Medical Blow-Fill-Seal
Extrusion PVC
Machining (precision plastic)
CNC Turning, Milling, Swiss Machining
EDM
Laser Processing
Metal Tube Drawing and Fabrication
Manufacturing & Assembly
Complex Assembly – from manual to fully automated
Metrology Labs & Capability Studies
Testing
Prototyping
Pad Printing
Laser Marking
In-Mold Labeling
Hot Stamping
Heat Staking
Welding – Spin, Sonic, Laser, RF, Induction
Bonding – UV & Solvent Adhesives
Surface Finishing including chemical etching, EP, tumbling and polishing
Surface Treatments & Coatings including HA, Ti, PTFE, Silicone, Plasma, Cryogenic Deflashing & others
Finished Device Services
Packaging and Design
Thermoform Packaging
Packaging Executing
Drug Handling and Filling
Sterilization Management
Logistics
https://directory.qmed.com/viant-comp238867.html
Viant is Dr. Sree Koneru's new home, 50 years in the medical device business.
Time for a lesson in 'Reading Quarterly Statements'
<<<<<< examine BIEL'S financials you will see that this "GIZMO" has NO margin >>>>>>
Q3 2021 Financial Statement, page 4
Sales ................ 414,687
Cost of Goods Sold ... 131,662
Gross Profit ......... 283,005
https://www.otcmarkets.com/otcapi/company/financial-report/311485/content
Gross Profit, $283,005 is 68.245% of Sales, $414,687 .
Gross Margin = 68.245%
https://www.omnicalculator.com/finance/margin#how-to-calculate-profit-margin
LOL, Is every company that has a 'Sale' a "Scam"?
KT Tape has plenty of profit margin in the Recovery + Wave with a $34 RRP.
Estimates on their per unit cost with retail packaging range between $8 to $9.
At full RRP that is a 74% gross margin, $25 profit.
On sale at $25 that is a 64% gross margin, $16 profit.
With an estimated mfg cost of $2.50 per unit BIEL is making good money selling to KT with many tens of thousands shipped.
72% gross margin at $9 with $6.50 per unit profit.
69% gross margin at $8 with a $ 5.50 per unit profit.
When RecoveryRx gets rolling the healthy ActiPatch margins will look small.
7 Million Share Buy at 12
Only 7.8 million shares remain on the 12 Ask Size.
21 million shares on the 11 Bid Size.
Next Ask on Level 2 is at 14.
Yep JGD, I've been drooling over Stada since KW Liked a couple of their Posts a year ago
"STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally."
"STADA focuses on a three pillar strategy consisting of generics, specialty pharma and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries."
Stada is an aggressive, growing pharmaceutical/OTC medical products company with Bain Capital's deep pockets:
‘Acquisitive and Entrepreneurial’ Stada Spies Further M&A Opportunities In US And Elsewhere
14 Apr 2021
https://hbw.pharmaintelligence.informa.com/RS151219/Acquisitive-and-Entrepreneurial-Stada-Spies-Further-MA-Opportunities-In-US-And-Elsewhere
STADA to acquire 16 consumer healthcare brands from Sanofi
June 29, 2021
https://www.pharmaceutical-technology.com/news/stada-sanofi-consumer-brands/
Stada Buys 15 Over-the-Counter Products from GSK for $325 Million
Published: Feb 24, 2020
https://www.biospace.com/article/generic-drugmaker-stada-to-buy-15-consumer-healthcare-products-from-gsk/
Stada AG acquires Lobsor Pharmaceuticals to enhance its presence in Neurological disease domain
October 16, 2020
https://www.sathguru.com/pharmforward/deals/stada-ag-acquires-lobsor-pharmaceuticals-to-enhance-its-presence-in-neurological-disease-domain/
Takeda Completes Sale of Select OTC and Non-Core Assets to STADA
March 4, 2020
https://www.takeda.com/newsroom/newsreleases/2020/takeda-completes-sale-of-select-otc-and-non-core-assets-to-stada/
STADA and Sanofi strike consumer healthcare distribution agreement in selected countries in Europe
27/07/2021
https://www.thorntonross.com/blog-landing/posts/2021/july/stada-and-sanofi-strike-consumer-healthcare-distribution-agreement-in-selected-countries-in-europe
Thanks Seven-up, BIEL Update Full of Good News
* $200k in New International Orders
* $3.6 Billion, 13,000 Employee Stada is now an ActiPatch Distributor in the Middle East (this is the Partner I have been waiting for, Stada is a massive company handling Medical Products Distribution in 120 Countries, look for expansion of ActiPatch Distribution in many of their 120 Countries)
* Ms. Anwar-Dean's expansion into Production Scheduling, Inventory Management, Order Fulfillment Management (this indicates an increase in demand for BIEL Products)
* Ms. Zoya Atiq's hiring as Medical Device Compliance Engineer, Technical Writing, Clinical Trial Writing (you don't hire a fulltime employee for Technical/Clinical Writing unless you plan on a large, sustained need for this expertise)
* Stanford Medical Center Clinical trial for Thumb Arthritis, 120 Patients (this is what BIEL needs, larger Trials from top shelf medical establishments and expansion of Indications)
* Dog Arthritis 70 patients, Higher Powered Device being Explored, Results due in a few months (finally after years of teasing actual testing of an Enhanced Actipatch, this is huge, ActiPatch is limited to 2" of penetration into the body and signal strength diminishes the deeper it goes, a higher powered ActiPatch opens up new uses and quicker results for existing uses)
* Total Knee Replacement, Major Surgical Center known for TKA, 180 patient plus 180 control group (this is a Retrospective Study meaning no waiting to recruit patients or gather the data, results due Summer 2022)
* UC San Diego Researchers in Pilot Stage of Studies on Refractory Phantom Pain & Total Knee/Hip Replacement Pain
* BIEL is in talks with 2 Research Teams for Studies on Wound Care
Please take note Largest Lenders charged BIEL Zero Interest in 2020 & 2021
And are doing so again in 2022.
https://www.bielcorp.com/bioelectronics-corporation-announces-major-lenders-forgoing-interest-for-a-3rd-consecutive-year-new-research-projects-underway/
Thanks Pro, about time these Shorting Schemes were investigated
Musk brings up an excellent point, it is the SEC who is supposed to police the financial markets. Why have they been MIA on this issue to the point where the DOJ needed to take action.
Going Long on a stock provides a financial benefit when a company succeeds and the SP goes up.
Shorting a stock provides financial benefit when a company fails and the SP goes down and the ultimate financial benefit if the company goes BK. Who could have guessed that this incentive would cause some to help that process along.
What are you basing the "19 days" on ?
I have been following BIEL for 12 years and the Q4 Financials have always come out with the EOY Financials on 3/31.
Q1, 2, 3 are due 45 days from the close of the quarter.
EOY Financials, which include Q4, are due 90 days after the EOY.
The exceptions would be if February had 29 Days or 3/31 lands on a weekend.
Even if you are counting 'Market Days', still way off.
BIEL could choose to Release early but that has never happened.
Nothing is due on 3/15/2022.
Apparently the OEM relationship was never properly explained to some
BIEL did not have the Financial Resources/Name Recognition/Distribution Network to Market ActiPatch in the US.
The OEM Partners have Financial Resources/Name Recognition/Distribution Networks and want innovative new products.
BIEL receives a Purchase Order from an OEM Partner. BIEL manufactures the devices and ships them to the OEM Partners. BIEL's end of the OEM Partnership is done. BIEL can focus on signing new OEM Partners and developing new products.
The OEM Partner puts their Marketing/Name Recognition/Distribution to work selling the products.
BIEL started supplying its OEM Partners in Q4 2020. Sales Revenue from the first 12 months of OEM Sales, Q4 2020 - Q3 2021, was $1.949 million. This is an increase of over $1 million when compared to full year 2020 sales of $829k or full year 2019 sales of $941k.
Thanks for the Opinion
<<<<<<<<<<<<<< Looks finished to me >>>>>>>>>>>>>>>>>>
Zero out of 12 is not much of a batting average so I will keep my money on BIEL.
2010 wrong
2011 wrong
2012 wrong
2013 wrong
2014 wrong
2015 wrong
2016 wrong
2017 wrong
2018 wrong
2019 wrong & BIEL gets FDA Post Surgery Clearance for RecoveryRx
2020 wrong & BIEL gets FDA Musculoskeletal OTC Clearance for ActiPatch
2021 wrong & BIEL has first profitable Quarter
LOL, Been here since 2010, same thing said every year
<<<<<<<<<<<< It's FINISHED >>>>>>>>>>>>>>>>
Always Wrong, 2022 prediction will be no different
LOL, there are people on this board who have supported BIEL for the last 10-15 years
10 months is a blip on screen.
4/2021 - I am a new investor in BIEL.. what sold me was the product works, not only for myself but for two other family members who have been in chronic pain for over a decade.. That's when I researched the company decided it's time to own shares. This is just a matter of time before the world finds out about this product and the pills are no longer needed for pain... all I see in the future for investors is big $$$
For those on the sidelines you're making a huge mistake
KT Tape is getting great exposure at the Winter Olympics
Normally KT Tape use during the Winter Games is hidden under winter clothing. This year Skiers are using it on their faces to shield from the cold and it is getting lots of attention.
https://www.usatoday.com/story/sports/olympics/beijing/2022/02/09/beijing-olympics-kt-tape/6721112001/
https://www.nytimes.com/2022/02/09/sports/olympics/skiing-face-tape.html
https://www.today.com/health/why-are-olympic-skiers-wearing-tape-their-faces-t122950
https://www.9news.com/article/sports/olympics/olympic-skiers-face-tape/73-39e1110f-c569-4228-81e4-786627e30c89
https://www.insider.com/olympic-athletes-face-tape-cold-ceo-warns-may-get-stuck-2022-2
https://www.businessinsider.co.za/olympic-athletes-face-tape-cold-ceo-warns-may-get-stuck-2022-2
LOL, Sounds like an Opinion as no documentation provided, but that is SOP
KT Wave, #39 in Exercise Machine Attachments / #91 in Pain Relief Homeopathic Remedies
https://www.amazon.com/KT-Tape-Recovery-Electromagnetic-Relief/dp/B08WTN6V2Y/ref=sr_1_2?adgrpid=1337006894468678&hvadid=83563032078343&hvbmt=bb&hvdev=c&hvlocphy=164327&hvnetw=o&hvqmt=b&hvtargid=kwd-83563405908324%3Aloc-190&hydadcr=16037_10546208&keywords=kt+wave+recovery&qid=1645544579&sr=8-2